BR112015024040A2 - preparação alergênica - Google Patents

preparação alergênica

Info

Publication number
BR112015024040A2
BR112015024040A2 BR112015024040A BR112015024040A BR112015024040A2 BR 112015024040 A2 BR112015024040 A2 BR 112015024040A2 BR 112015024040 A BR112015024040 A BR 112015024040A BR 112015024040 A BR112015024040 A BR 112015024040A BR 112015024040 A2 BR112015024040 A2 BR 112015024040A2
Authority
BR
Brazil
Prior art keywords
preparation
allergenic
allergenic preparation
allergen
oil
Prior art date
Application number
BR112015024040A
Other languages
English (en)
Inventor
Legon Thierry
Original Assignee
Biotech Tools Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Tools Sa filed Critical Biotech Tools Sa
Publication of BR112015024040A2 publication Critical patent/BR112015024040A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo da patente de invenção para: “preparação alergênica”. a presente invenção se refere a uma preparação alergênica compreendendo um alergênico em uma emulsão óleo-em-água
BR112015024040A 2013-03-19 2014-03-19 preparação alergênica BR112015024040A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13160006 2013-03-19
PCT/EP2014/055516 WO2014147131A1 (en) 2013-03-19 2014-03-19 Allergen preparation

Publications (1)

Publication Number Publication Date
BR112015024040A2 true BR112015024040A2 (pt) 2017-07-18

Family

ID=48013764

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015024040A BR112015024040A2 (pt) 2013-03-19 2014-03-19 preparação alergênica

Country Status (8)

Country Link
US (1) US20160030553A1 (pt)
EP (1) EP2976107B1 (pt)
JP (2) JP6419775B2 (pt)
CN (1) CN105120898A (pt)
AU (1) AU2014234316B2 (pt)
BR (1) BR112015024040A2 (pt)
CA (1) CA2903345A1 (pt)
WO (1) WO2014147131A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2768492C2 (ru) 2011-11-18 2022-03-24 Ридженерон Фармасьютикалз, Инк. Полимерные белковые микрочастицы
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10064936B2 (en) 2015-02-20 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
US11952510B2 (en) * 2016-09-23 2024-04-09 Devan Chemicals Textile coating composition
EP3522921B1 (en) * 2016-10-05 2020-12-23 ASIT BioTech s.a. Prevention of allergy
CA3069967A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. Methods for making mixed allergen compositions
CN108129558B (zh) * 2017-12-21 2021-10-12 中国医学科学院北京协和医院 一种桦树花粉主要致敏蛋白Bet v 8的提取和分离纯化方法及应用
WO2020154476A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) * 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
ATE375803T1 (de) * 1998-05-07 2007-11-15 Corixa Corp Adjuvanszusammensetzung und methoden zu deren verwendng
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US20030129251A1 (en) * 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
EP1625140A4 (en) * 2002-12-23 2008-06-18 Dynavax Tech Corp BRANCHED IMMUNOMODULAR COMPOUNDS AND METHOD OF USE THEREOF
JP2007189920A (ja) * 2006-01-17 2007-08-02 Osaka Prefecture Univ イヌアレルギーに対する予防又は治療作用を有するポリペプチド
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
PT2086582E (pt) * 2006-10-12 2013-01-25 Glaxosmithkline Biolog Sa Vacina compreendendo uma emulsão adjuvante óleo em água
US20100278880A1 (en) * 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
AU2012269031B2 (en) * 2011-06-15 2016-10-06 Biotech Tools S.A. A method for the production of hydrolyzed allergens

Also Published As

Publication number Publication date
WO2014147131A1 (en) 2014-09-25
JP2018168192A (ja) 2018-11-01
EP2976107B1 (en) 2019-02-20
EP2976107A1 (en) 2016-01-27
JP2016515554A (ja) 2016-05-30
JP6419775B2 (ja) 2018-11-07
US20160030553A1 (en) 2016-02-04
CA2903345A1 (en) 2014-09-25
AU2014234316B2 (en) 2018-09-27
CN105120898A (zh) 2015-12-02
AU2014234316A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
BR112015024040A2 (pt) preparação alergênica
FR21C1059I2 (fr) Compositions pharmaceutiques
CL2014001930A1 (es) Formulacion farmacéutica que comprende un anticuerpo angiopoyetina 2 (anti-ang2).
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
CL2014001781A1 (es) Metodo para mejorar la tolerancia gastrointestinal y/o reducir las complicaciones gastrointestinales que resultan de la administracion de biguanida.
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
BR302013006043S1 (pt) Configuração aplicada a uma cadeira
BR112016008736A2 (pt) formulação estável de insulina glulisina
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
BR112015006910A2 (pt) aparelho hidráulico que apresenta uma estrutura melhorada para sua cilindrada.
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
EP2982364A4 (en) OIL-LIKE EMULSION COMPOSITION IN WATER
BR112015006692A2 (pt) formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit.
DK3086653T3 (da) Fremgangsmåde til fremstilling af en lipidsammensætning uden palmeolie, anvendelse deraf i et fødevareprodukt
DK3003401T3 (da) Farmaceutisk præparat
ES2777200T8 (es) Procedimiento para la preparación de 3-aminopiperidina enriquecida enantioméricamente
BR112015009839A2 (pt) composição farmacêutica de tapentadol para administração parenteral
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional
BR112015033065A8 (pt) nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio
FR3008900B1 (fr) Nanoparticules lipidiques multicompartimentees
CL2015002013A1 (es) Composición alimenticia que comprende desferricrisina
EP2968164A4 (en) COMPOSITIONS AND METHODS OF ADMINISTRATION TO DYSPHAGIA SUBJECTS
FI20135228A (fi) Monikäyttötuoli

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements